It is a powerful tool, but it must be used with a doctor
A new class of weight loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists holds promise
High-quality human clinical trials are lacking, and optimal dosing, long-term safety, and efficacy have not been established, meaning its use for IBS and Crohns should be considered investigational rather than a standard therapeutic option
It works best when combined with dietary changes and increased physical activity
We charge no fees unless we win
Write a review PRODUCT REVIEWS Advertising Disclosure FTC Disclosure As the owner/sponsor of this blog , we have the full intention to be compliant with the Federal Trade Commission (FTC) rules about the use of testimonials, endorsements, and overall content in advertising and marketing